iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine ProgramGlobeNewsWire • 05/06/21
iBio, Inc. (IBIO) CEO Tom Isett on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/17/21
iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/16/21
iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021GlobeNewsWire • 02/09/21